Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 154Lymphoma 78Lymphoma, Non-Hodgkin 62Neoplasms, Plasma Cell 54Leukemia 52Leukemia, Myeloid, Acute 49Hodgkin Disease 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Leukemia, Lymphocytic, Chronic, B-Cell 45Myelodysplastic Syndromes 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, Follicular 40Lymphoma, Mantle-Cell 38Lymphoma, Large-Cell, Immunoblastic 29Neuroblastoma 27Burkitt Lymphoma 27Lymphoma, B-Cell, Marginal Zone 26Recurrence 22Immunoglobulin Light-chain Amyloidosis 22Myeloproliferative Disorders 18Leukemia, Myeloid, Accelerated Phase 16Hematologic Neoplasms 16Congenital Abnormalities 16Leukemia, Myeloid, Chronic-Phase 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Graft vs Host Disease 14Dendritic Cell Sarcoma, Interdigitating 14Waldenstrom Macroglobulinemia 13Leukemia, Myelomonocytic, Chronic 13Blast Crisis 13

Interventions

fludarabine phosphate 2fludarabine 2Thiotepa 2Surveys and Questionnaires 2Melphalan 2Fentanyl 2voxelotor 1maltodextrin 1Whole-Body Irradiation 1Range of Motion, Articular 1Interviews as Topic 1Imagery, Psychotherapy 1Glutamine 1Erythrocyte Count 1Cyclophosphamide 1Clofarabine 1Busulfan 1Blood Transfusion 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Anemia, Sickle Cell × Melphalan × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡